Protalix BioTherapeutics (PLX) Other Gross PP&E Adjustments (2016 - 2025)
Protalix BioTherapeutics (PLX) has 15 years of Other Gross PP&E Adjustments data on record, last reported at -$7.8 million in Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments fell 38.35% year-over-year to -$7.8 million; the TTM value through Sep 2025 reached -$7.8 million, down 38.35%, while the annual FY2024 figure was $34.9 million, 3.4% up from the prior year.
- Other Gross PP&E Adjustments reached -$7.8 million in Q3 2025 per PLX's latest filing, down from -$5.0 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $34.9 million in Q4 2024 and bottomed at -$7.8 million in Q3 2025.
- Average Other Gross PP&E Adjustments over 5 years is $2.7 million, with a median of -$5.2 million recorded in 2025.
- The widest YoY moves for Other Gross PP&E Adjustments: up 12.79% in 2025, down 38.35% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $32.8 million in 2021, then rose by 1.22% to $33.2 million in 2022, then increased by 1.81% to $33.8 million in 2023, then grew by 3.4% to $34.9 million in 2024, then crashed by 122.38% to -$7.8 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$7.8 million in Q3 2025, -$5.0 million in Q2 2025, and -$5.2 million in Q1 2025.